Primary diffuse large B-cell lymphoma of the head and neck in a Brazilian single-center study

Paula Sabbo Bernardo1, Thaís Hancio1, Flavia da Cunha Vasconcelos1

  • 1Laboratório de Hemato-Oncologia Celular e Molecular, Programa de Hemato-Oncologia Molecular, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil.

Oral Diseases
|December 14, 2021
PubMed

Insights

Head and neck diffuse large B-cell lymphoma (DLBCL) is common in middle-aged and elderly Brazilians. Treatment significantly improves overall survival, while advanced age, male gender, high LDH, and HIV positivity are linked to poorer outcomes.

Area of Science:

  • Oncology
  • Epidemiology
  • Hematology

Background:

  • Diffuse large B-cell lymphoma (DLBCL) accounts for a significant proportion of head and neck cancers.
  • Understanding the epidemiological and survival characteristics of head and neck DLBCL is crucial for patient management.

Purpose of the Study:

  • To characterize demographic parameters, anatomical sites, and survival rates of patients with head and neck DLBCL in a Brazilian cancer center.
  • To identify factors associated with overall survival in this patient cohort.

Main Methods:

  • Retrospective epidemiological study of 243 head and neck DLBCL patients.
  • Data collected included demographics, tumor location, HIV status, lactate dehydrogenase (LDH) levels, and treatment modalities.
  • Statistical analysis was performed to determine associations with overall survival.

Main Results:

  • Waldeyer's ring was the most frequent primary tumor site.
  • Age over 80, male gender, elevated LDH, and HIV positivity were associated with significantly shorter overall survival (OS).
  • Treatment demonstrated a protective effect on OS, whereas combined chemotherapy and radiotherapy showed no additional benefit over isolated modalities.

Conclusions:

  • Head and neck DLBCL predominantly affects middle-aged and elderly individuals, with a slight male predominance in the Brazilian population studied.
  • A 3-year OS rate of nearly 60% was observed.
  • Multivariate analysis identified treatment as the sole significant protective factor for OS.
Abstract